Proteasome subunit beta type-2 (PSMB2)

The protein contains 201 amino acids for an estimated molecular weight of 22836 Da.

 

Non-catalytic component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex). (updated: Feb. 10, 2021)

Protein identification was indicated in the following studies:

  1. Goodman and co-workers. (2013) The proteomics and interactomics of human erythrocytes. Exp Biol Med (Maywood) 238(5), 509-518.
  2. Lange and co-workers. (2014) Annotating N termini for the human proteome project: N termini and Nα-acetylation status differentiate stable cleaved protein species from degradation remnants in the human erythrocyte proteome. J Proteome Res. 13(4), 2028-2044.
  3. Hegedűs and co-workers. (2015) Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications. Database (Oxford) 1-8.
  4. Wilson and co-workers. (2016) Comparison of the Proteome of Adult and Cord Erythroid Cells, and Changes in the Proteome Following Reticulocyte Maturation. Mol Cell Proteomics. 15(6), 1938-1946.
  5. Bryk and co-workers. (2017) Quantitative Analysis of Human Red Blood Cell Proteome. J Proteome Res. 16(8), 2752-2761.
  6. D'Alessandro and co-workers. (2017) Red blood cell proteomics update: is there more to discover? Blood Transfus. 15(2), 182-187.
  7. Chu and co-workers. (2018) Quantitative mass spectrometry of human reticulocytes reveal proteome-wide modifications during maturation. Br J Haematol. 180(1), 118-133.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

Interpro domains
Total structural coverage: 100%
Model score: 100
No model available.

(right-click above to access to more options from the contextual menu)

Biological Process

Anaphase-promoting complex-dependent catabolic process GO Logo
Antigen processing and presentation of exogenous peptide antigen via MHC class I GO Logo
Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent GO Logo
Antigen processing and presentation of peptide antigen via MHC class I GO Logo
Apoptotic process GO Logo
Cellular nitrogen compound metabolic process GO Logo
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest GO Logo
Fc-epsilon receptor signaling pathway GO Logo
G1/S transition of mitotic cell cycle GO Logo
Gene expression GO Logo
Interleukin-1-mediated signaling pathway GO Logo
MAPK cascade GO Logo
Mitotic cell cycle GO Logo
Negative regulation of apoptotic process GO Logo
Negative regulation of canonical Wnt signaling pathway GO Logo
Negative regulation of G2/M transition of mitotic cell cycle GO Logo
NIK/NF-kappaB signaling GO Logo
Obsolete negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle GO Logo
Obsolete positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition GO Logo
Obsolete regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle GO Logo
Positive regulation of canonical Wnt signaling pathway GO Logo
Post-translational protein modification GO Logo
Pre-replicative complex assembly GO Logo
Proteasomal protein catabolic process GO Logo
Proteasomal ubiquitin-independent protein catabolic process GO Logo
Proteasome-mediated ubiquitin-dependent protein catabolic process GO Logo
Protein deubiquitination GO Logo
Protein polyubiquitination GO Logo
Proteolysis involved in cellular protein catabolic process GO Logo
Regulation of apoptotic process GO Logo
Regulation of cellular amino acid metabolic process GO Logo
Regulation of hematopoietic stem cell differentiation GO Logo
Regulation of mitotic cell cycle phase transition GO Logo
Regulation of mRNA stability GO Logo
Regulation of transcription from RNA polymerase II promoter in response to hypoxia GO Logo
Response to organic cyclic compound GO Logo
Response to organonitrogen compound GO Logo
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process GO Logo
Small molecule metabolic process GO Logo
Stimulatory C-type lectin receptor signaling pathway GO Logo
T cell receptor signaling pathway GO Logo
Transmembrane transport GO Logo
Tumor necrosis factor-mediated signaling pathway GO Logo
Viral process GO Logo
Wnt signaling pathway, planar cell polarity pathway GO Logo

The reference OMIM entry for this protein is 602175

Proteasome subunit, beta-type, 2; psmb2
Proteasome subunit beta-4

The proteasome is responsible for degradation of short lived and misfolded cytosolic and nuclear proteins in the cell. It consists of a complex of proteins that form a 20S core particle in both prokaryotes and eukaryotes. The 20S proteasome is composed of 7 alpha and 7 beta subunits that dimerize to form an alpha(7)beta(7)beta(7)alpha(7) structure. Subunits are designated alpha or beta depending on their homology to the Thermoplasma acidophilus proteasome in which the beta subunits are catalytically active. The 20S core complex associates with regulatory proteins that function as proteasome activators in vivo. One pathway of activation uses a 19S complex that is involved in the ubiquitin (191339) pathway of protein breakdown. The PA28 complex is an alternative proteasome activator that does not employ the use of ubiquitin. The complex is composed of 2 homologous subunits called alpha and beta, which form a hexameric ring. PA28 appears to be involved in the presentation of endogenous antigens by MHC class I molecules. The PA28 complex is expressed constitutively in antigen-presenting cells, and its expression is upregulated by interferon gamma (147570). Many of the genes involved in class I antigen presentation are encoded within the MHC, including the 2 proteasome subunits PSMB9 (177045), also known as LMP2, and PSMB8 (177046), also known as LMP7. McCusker et al. (1997) completed the mapping of the human proteasome beta-type genes: by fluorescence in situ hybridization they mapped the PSMB2 gene to 1p34.2, the PSMB3 gene (602176) to 2q35, and the PSMB4 gene (602177) to 1q21. They also showed that the genes encoding the alpha (600654) and beta (602161) subunits of the PA28 complex are closely linked on 14q11.2, within 1 Mb of the beta proteasome locus PSMB5 (600306). Thus, with the exception of the genes encoding the PSMB9 and PSMB8 subunits, the beta genes are not closely linked in the human genome. PSMB2 and PSMB4 map to regions of chromosome 1 that are proposed to be paralogous to regions of the human genome where other beta proteasome genes map: chromosome 6, containing the major histocompatibility complex, and chromosome 9. ... More on the omim web site

Subscribe to this protein entry history

Feb. 16, 2021: Protein entry updated
Automatic update: Entry updated from uniprot information.

Feb. 10, 2018: Protein entry updated
Automatic update: Entry updated from uniprot information.

Feb. 2, 2018: Protein entry updated
Automatic update: Uniprot description updated

Dec. 19, 2017: Protein entry updated
Automatic update: Uniprot description updated

Nov. 23, 2017: Protein entry updated
Automatic update: Uniprot description updated

March 16, 2016: Protein entry updated
Automatic update: OMIM entry 602175 was added.